BRIEF published on 04/02/2024 at 15:05, 5 months 17 days ago Edesa Biotech participera aux prochaines conférences d'investisseurs Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs
PRESS RELEASE published on 04/02/2024 at 15:00, 5 months 17 days ago Edesa Biotech to Participate in Upcoming Investor Conferences Edesa Biotech, Inc. announces participation in upcoming investor conferences in Toronto, London, and New York to present innovative treatments for immuno-inflammatory diseases Clinical-stage Biopharmaceutical Company Immuno-inflammatory Diseases Investor Conferences Edesa Biotech Inc. Therapeutics
BRIEF published on 03/21/2024 at 21:35, 5 months 28 days ago Edesa Biotech participera à la conférence HC Wainwright sur les maladies auto-immunes et inflammatoires Maladies Inflammatoires Edesa Biotechnologie Conférence Auto-immune Discussion Au Coin Du Feu Produits Biopharmaceutiques Au Stade Clinique
BRIEF published on 03/21/2024 at 21:35, 5 months 28 days ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Fireside Chat Edesa Biotech Inflammatory Diseases Autoimmune Conference Clinical-Stage Biopharmaceutical
PRESS RELEASE published on 03/21/2024 at 21:30, 5 months 28 days ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Edesa Biotech to participate in H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference. Fireside Chat with CEO Par Nijhawan, MD and analyst scheduled for March 28, 2024 Fireside Chat Edesa Biotech H.C. Wainwright Autoimmune & Inflammatory Disease Par Nijhawan
BRIEF published on 03/07/2024 at 14:50, 6 months 12 days ago Edesa Biotech to Showcase at Barclays Global Healthcare Conference Clinical Trials Edesa Biotech Immunotherapy Barclays Healthcare Conference ARDS
BRIEF published on 03/07/2024 at 14:50, 6 months 12 days ago Edesa Biotech sera présent à la conférence Barclays Global Healthcare Immunothérapie Essais Cliniques Edesa Biotechnologie Conférence Barclays Sur La Santé SDRA
PRESS RELEASE published on 03/07/2024 at 14:45, 6 months 12 days ago Edesa Biotech to Participate in Barclays Global Healthcare Conference Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Barclays 26th Annual Global Healthcare Conference in Miami. Company focuses on developing host-directed therapeutics for immuno-inflammatory diseases Biopharmaceutical Company Edesa Biotech NASDAQ:EDSA Barclays 26th Annual Global Healthcare Conference Immune-related Diseases
BRIEF published on 03/04/2024 at 22:35, 6 months 14 days ago Edesa Biotech participera aux prochaines réunions de dermatologie Biopharmaceutique Essais Cliniques Edesa Biotechnologie Dermatologie Maladies Immuno-inflammatoires
BRIEF published on 03/04/2024 at 22:35, 6 months 14 days ago Edesa Biotech to Participate in Upcoming Dermatology Meetings Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Dermatology
Published on 09/19/2024 at 17:30, 48 minutes ago Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Published on 09/19/2024 at 17:00, 1 hour 18 minutes ago Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Published on 09/19/2024 at 15:45, 2 hours 33 minutes ago eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Published on 09/19/2024 at 15:20, 2 hours 58 minutes ago Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Published on 09/19/2024 at 15:01, 3 hours 17 minutes ago ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Published on 09/19/2024 at 17:52, 25 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 25 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:52, 26 minutes ago EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Published on 09/19/2024 at 17:45, 33 minutes ago AFG Holding SA acquiert une participation majoritaire dans le groupe allemand Access Holding et prend ainsi le contrôle de
Published on 09/19/2024 at 17:45, 33 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 33 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 33 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)